| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CTP binding | 5.91e-05 | 2 | 154 | 2 | GO:0002135 | |
| GeneOntologyMolecularFunction | gamma-catenin binding | 9.40e-05 | 12 | 154 | 3 | GO:0045295 | |
| GeneOntologyMolecularFunction | 24-hydroxycholesterol 7alpha-hydroxylase activity | 1.76e-04 | 3 | 154 | 2 | GO:0033782 | |
| GeneOntologyMolecularFunction | sulfonylurea receptor binding | 1.76e-04 | 3 | 154 | 2 | GO:0017098 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | MARK3 SNRK WNK1 STK32A NEK2 EGFR IKBKE RPS6KA6 EIF2AK4 TSSK1B TSSK4 WNK3 | 1.82e-04 | 446 | 154 | 12 | GO:0004674 |
| GeneOntologyMolecularFunction | protein kinase activity | MARK3 SNRK WNK1 STK32A MET FRK NEK2 EGFR IKBKE RPS6KA6 EIF2AK4 TSSK1B TSSK4 WNK3 | 2.33e-04 | 600 | 154 | 14 | GO:0004672 |
| GeneOntologyMolecularFunction | UTP binding | 3.51e-04 | 4 | 154 | 2 | GO:0002134 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | MARK3 DGKZ SNRK WNK1 STK32A MET FRK NEK2 EGFR IKBKE RPS6KA6 EIF2AK4 TSSK1B TSSK4 WNK3 | 3.95e-04 | 709 | 154 | 15 | GO:0016773 |
| GeneOntologyMolecularFunction | protein serine kinase activity | MARK3 SNRK WNK1 STK32A NEK2 RPS6KA6 EIF2AK4 TSSK1B TSSK4 WNK3 | 5.28e-04 | 363 | 154 | 10 | GO:0106310 |
| GeneOntologyMolecularFunction | pyrimidine ribonucleotide binding | 5.82e-04 | 5 | 154 | 2 | GO:0032557 | |
| GeneOntologyMolecularFunction | dATP binding | 5.82e-04 | 5 | 154 | 2 | GO:0032564 | |
| GeneOntologyMolecularFunction | transcription factor binding | MAGEA2 TEAD2 TCF7L2 PRAMEF5 ZNF618 GATA1 EOMES NFATC2 NR5A2 C1D TBXT PRAMEF26 LEF1 PRAMEF6 HDAC1 | 7.36e-04 | 753 | 154 | 15 | GO:0008134 |
| GeneOntologyMolecularFunction | transcription coregulator binding | 7.66e-04 | 140 | 154 | 6 | GO:0001221 | |
| GeneOntologyMolecularFunction | kinase activity | MARK3 DGKZ SNRK WNK1 STK32A MET FRK NEK2 EGFR IKBKE RPS6KA6 EIF2AK4 TSSK1B TSSK4 WNK3 | 8.53e-04 | 764 | 154 | 15 | GO:0016301 |
| GeneOntologyMolecularFunction | adenyl deoxyribonucleotide binding | 8.69e-04 | 6 | 154 | 2 | GO:0032558 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | MARK3 DGKZ SNRK WNK1 STK32A PARP6 MET FRK NEK2 EGFR IKBKE RPS6KA6 PCYT2 EIF2AK4 TSSK1B TSSK4 WNK3 | 9.37e-04 | 938 | 154 | 17 | GO:0016772 |
| GeneOntologyMolecularFunction | phosphatase binding | 1.04e-03 | 264 | 154 | 8 | GO:0019902 | |
| GeneOntologyMolecularFunction | purine deoxyribonucleotide binding | 1.21e-03 | 7 | 154 | 2 | GO:0032554 | |
| GeneOntologyMolecularFunction | lysophospholipase activity | 1.42e-03 | 29 | 154 | 3 | GO:0004622 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | TCF7L2 PRAMEF5 GATA1 EOMES C1D TBXT PRAMEF26 LEF1 PRAMEF6 HDAC1 | 1.51e-03 | 417 | 154 | 10 | GO:0061629 |
| GeneOntologyMolecularFunction | TPR domain binding | 1.61e-03 | 8 | 154 | 2 | GO:0030911 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 2.05e-03 | 9 | 154 | 2 | GO:0070016 | |
| GeneOntologyMolecularFunction | deoxyribonucleotide binding | 2.05e-03 | 9 | 154 | 2 | GO:0032552 | |
| GeneOntologyCellularComponent | chromatin | UBR2 TEAD2 ACTR8 TCF7 TCF7L2 PRAMEF5 ZNF618 ICE2 AHCTF1 TBX21 GATA1 NAP1L2 EOMES FANCG NFATC2 UBR5 UCHL5 NR5A2 SMARCA2 HSFX1 TBXT PRAMEF26 LEF1 PRAMEF6 HDAC1 | 7.27e-05 | 1480 | 153 | 25 | GO:0000785 |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 1.04e-04 | 13 | 153 | 3 | GO:1990907 | |
| Domain | CTNNB1_binding | 2.02e-06 | 4 | 150 | 3 | PF08347 | |
| Domain | TCF/LEF | 2.02e-06 | 4 | 150 | 3 | IPR024940 | |
| Domain | CTNNB1-bd_N | 2.02e-06 | 4 | 150 | 3 | IPR013558 | |
| Domain | PROTEIN_KINASE_ATP | MARK3 SNRK WNK1 STK32A MET FRK NEK2 EGFR IKBKE RPS6KA6 EIF2AK4 TSSK1B TSSK4 WNK3 | 2.05e-05 | 459 | 150 | 14 | PS00107 |
| Domain | Kinase-like_dom | MARK3 SNRK WNK1 STK32A MET FRK NEK2 PTPN13 EGFR IKBKE RPS6KA6 EIF2AK4 TSSK1B TSSK4 WNK3 | 3.19e-05 | 542 | 150 | 15 | IPR011009 |
| Domain | Prot_kinase_dom | MARK3 SNRK WNK1 STK32A MET FRK NEK2 EGFR IKBKE RPS6KA6 EIF2AK4 TSSK1B TSSK4 WNK3 | 4.10e-05 | 489 | 150 | 14 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | MARK3 SNRK WNK1 STK32A MET FRK NEK2 EGFR IKBKE RPS6KA6 EIF2AK4 TSSK1B TSSK4 WNK3 | 4.48e-05 | 493 | 150 | 14 | PS50011 |
| Domain | UPF0028 | 6.41e-05 | 2 | 150 | 2 | PS01237 | |
| Domain | Catenin_binding_dom | 8.12e-05 | 29 | 150 | 4 | IPR027397 | |
| Domain | - | 8.12e-05 | 29 | 150 | 4 | 4.10.900.10 | |
| Domain | Ser/Thr_kinase_AS | MARK3 SNRK WNK1 STK32A NEK2 IKBKE RPS6KA6 EIF2AK4 TSSK1B TSSK4 WNK3 | 1.49e-04 | 357 | 150 | 11 | IPR008271 |
| Domain | S_TKc | MARK3 SNRK WNK1 STK32A NEK2 IKBKE RPS6KA6 EIF2AK4 TSSK1B TSSK4 WNK3 | 1.56e-04 | 359 | 150 | 11 | SM00220 |
| Domain | PROTEIN_KINASE_ST | MARK3 SNRK WNK1 STK32A NEK2 IKBKE RPS6KA6 EIF2AK4 TSSK1B TSSK4 WNK3 | 1.68e-04 | 362 | 150 | 11 | PS00108 |
| Domain | Vav | 1.91e-04 | 3 | 150 | 2 | IPR028530 | |
| Domain | Heat_shock_protein_90_CS | 1.91e-04 | 3 | 150 | 2 | IPR019805 | |
| Domain | Protein_kinase_ATP_BS | MARK3 SNRK STK32A MET FRK EGFR IKBKE RPS6KA6 EIF2AK4 TSSK1B TSSK4 | 2.50e-04 | 379 | 150 | 11 | IPR017441 |
| Domain | Pkinase | MARK3 SNRK WNK1 STK32A NEK2 IKBKE RPS6KA6 EIF2AK4 TSSK1B TSSK4 WNK3 | 2.61e-04 | 381 | 150 | 11 | PF00069 |
| Domain | TF_T-box | 3.18e-04 | 17 | 150 | 3 | IPR001699 | |
| Domain | TBOX | 3.18e-04 | 17 | 150 | 3 | SM00425 | |
| Domain | TF_T-box_CS | 3.18e-04 | 17 | 150 | 3 | IPR018186 | |
| Domain | - | 3.18e-04 | 17 | 150 | 3 | 2.60.40.820 | |
| Domain | TBOX_3 | 3.18e-04 | 17 | 150 | 3 | PS50252 | |
| Domain | T-box | 3.18e-04 | 17 | 150 | 3 | PF00907 | |
| Domain | TBOX_1 | 3.18e-04 | 17 | 150 | 3 | PS01283 | |
| Domain | TBOX_2 | 3.18e-04 | 17 | 150 | 3 | PS01264 | |
| Domain | HATPase_c | 3.79e-04 | 18 | 150 | 3 | SM00387 | |
| Domain | Hsp90_fam | 3.80e-04 | 4 | 150 | 2 | IPR001404 | |
| Domain | Hsp90_N | 3.80e-04 | 4 | 150 | 2 | IPR020575 | |
| Domain | HSP90 | 3.80e-04 | 4 | 150 | 2 | PF00183 | |
| Domain | HSP90 | 3.80e-04 | 4 | 150 | 2 | PS00298 | |
| Domain | HATPase_c | 4.48e-04 | 19 | 150 | 3 | PF02518 | |
| Domain | - | 5.24e-04 | 20 | 150 | 3 | 3.30.565.10 | |
| Domain | HATPase_C | 6.07e-04 | 21 | 150 | 3 | IPR003594 | |
| Domain | PolyA | 6.31e-04 | 5 | 150 | 2 | SM00517 | |
| Domain | - | 6.31e-04 | 5 | 150 | 2 | 1.10.1900.10 | |
| Domain | PABP | 6.31e-04 | 5 | 150 | 2 | PF00658 | |
| Domain | Cyt_P450_CYP7A1-type | 6.31e-04 | 5 | 150 | 2 | IPR024204 | |
| Domain | PABC | 6.31e-04 | 5 | 150 | 2 | PS51309 | |
| Domain | PABP_HYD | 6.31e-04 | 5 | 150 | 2 | IPR002004 | |
| Domain | p53-like_TF_DNA-bd | 8.62e-04 | 53 | 150 | 4 | IPR008967 | |
| Domain | OSR1_C | 9.41e-04 | 6 | 150 | 2 | PF12202 | |
| Domain | Kinase_OSR1/WNK_CCT | 9.41e-04 | 6 | 150 | 2 | IPR024678 | |
| Domain | PTPc_motif | 1.29e-03 | 59 | 150 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 1.29e-03 | 59 | 150 | 4 | IPR003595 | |
| Domain | CAMSAP_CH | 1.31e-03 | 7 | 150 | 2 | PF11971 | |
| Domain | ZnF_UBR1 | 1.31e-03 | 7 | 150 | 2 | SM00396 | |
| Domain | ZF_UBR | 1.31e-03 | 7 | 150 | 2 | PS51157 | |
| Domain | CAMSAP_CH | 1.31e-03 | 7 | 150 | 2 | IPR022613 | |
| Domain | zf-UBR | 1.31e-03 | 7 | 150 | 2 | PF02207 | |
| Domain | Znf_UBR | 1.31e-03 | 7 | 150 | 2 | IPR003126 | |
| Domain | ZF_DAG_PE_1 | 1.75e-03 | 64 | 150 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.75e-03 | 64 | 150 | 4 | PS50081 | |
| Domain | C1 | 1.85e-03 | 65 | 150 | 4 | SM00109 | |
| Domain | CH | 1.85e-03 | 65 | 150 | 4 | SM00033 | |
| Domain | PE/DAG-bd | 1.96e-03 | 66 | 150 | 4 | IPR002219 | |
| Domain | RhoGEF | 2.18e-03 | 68 | 150 | 4 | SM00325 | |
| Domain | rSAM | 2.22e-03 | 9 | 150 | 2 | IPR007197 | |
| Domain | Patatin | 2.22e-03 | 9 | 150 | 2 | PF01734 | |
| Domain | PNPLA | 2.22e-03 | 9 | 150 | 2 | PS51635 | |
| Domain | Patatin/PLipase_A2-rel | 2.22e-03 | 9 | 150 | 2 | IPR002641 | |
| Domain | Radical_SAM | 2.22e-03 | 9 | 150 | 2 | PF04055 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 2.31e-03 | 69 | 150 | 4 | IPR020636 | |
| Domain | RhoGEF | 2.43e-03 | 70 | 150 | 4 | PF00621 | |
| Domain | CH | 2.43e-03 | 70 | 150 | 4 | PF00307 | |
| Domain | DH_2 | 2.43e-03 | 70 | 150 | 4 | PS50010 | |
| Domain | - | 2.56e-03 | 71 | 150 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 2.56e-03 | 71 | 150 | 4 | IPR000219 | |
| Domain | - | 2.56e-03 | 71 | 150 | 4 | 1.10.418.10 | |
| Domain | Cyt_P450_E_grp-IV | 2.76e-03 | 10 | 150 | 2 | IPR002403 | |
| Domain | CH | 2.83e-03 | 73 | 150 | 4 | PS50021 | |
| Domain | CH-domain | 3.12e-03 | 75 | 150 | 4 | IPR001715 | |
| Domain | GDS_CDC24_CS | 3.75e-03 | 39 | 150 | 3 | IPR001331 | |
| Domain | - | 4.39e-03 | 391 | 150 | 9 | 2.30.29.30 | |
| Domain | TYR_PHOSPHATASE_1 | 5.10e-03 | 86 | 150 | 4 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 5.31e-03 | 87 | 150 | 4 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 5.31e-03 | 87 | 150 | 4 | PS50056 | |
| Domain | Myotubularin-like_Pase_dom | 5.47e-03 | 14 | 150 | 2 | IPR010569 | |
| Domain | PPASE_MYOTUBULARIN | 5.47e-03 | 14 | 150 | 2 | PS51339 | |
| Domain | Myotubularin_fam | 5.47e-03 | 14 | 150 | 2 | IPR030564 | |
| Domain | Myotub-related | 5.47e-03 | 14 | 150 | 2 | PF06602 | |
| Domain | - | 6.47e-03 | 92 | 150 | 4 | 3.90.190.10 | |
| Domain | GRAM | 7.14e-03 | 16 | 150 | 2 | SM00568 | |
| Domain | PH_dom-like | 7.57e-03 | 426 | 150 | 9 | IPR011993 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION | 1.81e-07 | 17 | 114 | 5 | M48240 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION | 2.77e-07 | 8 | 114 | 4 | MM17229 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 3.81e-06 | 14 | 114 | 4 | M27402 | |
| Pathway | REACTOME_FORMATION_OF_AXIAL_MESODERM | 3.81e-06 | 14 | 114 | 4 | M46441 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 6.85e-06 | 16 | 114 | 4 | MM17241 | |
| Pathway | REACTOME_GERM_LAYER_FORMATION_AT_GASTRULATION | 8.90e-06 | 17 | 114 | 4 | M45017 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY | 1.01e-05 | 6 | 114 | 3 | M47736 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 1.01e-05 | 6 | 114 | 3 | MM15542 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY | 1.76e-05 | 7 | 114 | 3 | M47465 | |
| Pathway | KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY | 2.80e-05 | 8 | 114 | 3 | M47413 | |
| Pathway | REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS | 2.80e-05 | 8 | 114 | 3 | M27359 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 2.80e-05 | 8 | 114 | 3 | M27821 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 5.29e-05 | 26 | 114 | 4 | MM14793 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 5.93e-05 | 10 | 114 | 3 | MM15156 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY | 5.93e-05 | 10 | 114 | 3 | M47486 | |
| Pathway | REACTOME_PI_METABOLISM | 5.96e-05 | 84 | 114 | 6 | M676 | |
| Pathway | KEGG_PROSTATE_CANCER | 8.25e-05 | 89 | 114 | 6 | M13191 | |
| Pathway | REACTOME_GASTRULATION | 8.34e-05 | 129 | 114 | 7 | M46433 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY | 1.07e-04 | 12 | 114 | 3 | M47410 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 1.19e-04 | 95 | 114 | 6 | M48268 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.22e-04 | 32 | 114 | 4 | MM14975 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 1.41e-04 | 98 | 114 | 6 | M39830 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 2.68e-04 | 39 | 114 | 4 | MM17226 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 3.07e-04 | 73 | 114 | 5 | M638 | |
| Pathway | REACTOME_FORMATION_OF_DEFINITIVE_ENDODERM | 3.22e-04 | 17 | 114 | 3 | M48030 | |
| Pathway | WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS | 3.22e-04 | 17 | 114 | 3 | M39443 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 3.58e-04 | 42 | 114 | 4 | M27272 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 3.70e-04 | 76 | 114 | 5 | MM15520 | |
| Pathway | REACTOME_PI_METABOLISM | 3.94e-04 | 77 | 114 | 5 | MM14590 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 4.70e-04 | 80 | 114 | 5 | M223 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL6A3 WWP1 NCBP1 MET EGFR ELMO2 VAV3 FLRT1 VAV2 HSP90AA1 HDAC1 | 5.67e-04 | 418 | 114 | 11 | MM15587 |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 6.21e-04 | 85 | 114 | 5 | M27079 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPH_TO_TCR_NFAT_SIGNALING_PATHWAY | 6.38e-04 | 5 | 114 | 2 | M48994 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL6A3 TCF7 TCF7L2 DSC3 MET EGFR VAV3 LEF1 VAV2 HSP90AA1 HDAC1 HSP90AB1 | 7.45e-04 | 502 | 114 | 12 | MM14537 |
| Pathway | KEGG_ENDOMETRIAL_CANCER | 8.14e-04 | 52 | 114 | 4 | M19877 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | TIAM2 PTPN13 WDR6 ELMO2 SYDE2 ITSN2 VAV3 ARHGAP45 VAV2 HSP90AA1 HSP90AB1 | 8.50e-04 | 439 | 114 | 11 | MM15595 |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 8.53e-04 | 137 | 114 | 6 | M48232 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | 8.75e-04 | 53 | 114 | 4 | M662 | |
| Pathway | REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN | 9.52e-04 | 6 | 114 | 2 | M27430 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | TIAM2 PTPN13 WDR6 ELMO2 SYDE2 ITSN2 VAV3 ARHGAP45 VAV2 HSP90AA1 HSP90AB1 | 1.04e-03 | 450 | 114 | 11 | M27078 |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 1.07e-03 | 143 | 114 | 6 | M39591 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 1.08e-03 | 96 | 114 | 5 | M27784 | |
| Pathway | WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES | 1.15e-03 | 57 | 114 | 4 | M39877 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | GABRB2 COL6A3 WWP1 NCBP1 MET EGFR ELMO2 VAV3 FLRT1 VAV2 HSP90AA1 HDAC1 | 1.23e-03 | 532 | 114 | 12 | M27870 |
| Pathway | REACTOME_CARDIOGENESIS | 1.31e-03 | 27 | 114 | 3 | M48011 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 1.31e-03 | 27 | 114 | 3 | M27422 | |
| Pathway | REACTOME_GLYCEROPHOSPHOLIPID_CATABOLISM | 1.33e-03 | 7 | 114 | 2 | M27657 | |
| Pathway | REACTOME_EPITHELIAL_MESENCHYMAL_TRANSITION_EMT_DURING_GASTRULATION | 1.33e-03 | 7 | 114 | 2 | M46431 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 1.41e-03 | 151 | 114 | 6 | M19428 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 1.51e-03 | 153 | 114 | 6 | M39546 | |
| Pathway | KEGG_THYROID_CANCER | 1.61e-03 | 29 | 114 | 3 | M523 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 1.62e-03 | 211 | 114 | 7 | M649 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | UBR2 TCF7L2 MARK3 WWP1 ANXA6 ACP3 LARP1 CEP192 ATAT1 PPM1H SIL1 LRCH3 PTPN13 PNPLA6 PTPRE EGFR KLHL23 KCNMA1 SMARCA2 EIF2AK4 PNPLA7 PLOD1 ZDHHC13 VAV2 TBCD FBXW11 | 3.29e-09 | 1489 | 157 | 26 | 28611215 |
| Pubmed | 5.12e-08 | 75 | 157 | 7 | 15951569 | ||
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 1.92e-07 | 12 | 157 | 4 | 11266540 | |
| Pubmed | DNAH10 MARK3 WWP1 WNK1 FRK NEK2 PTPRE EGFR UCHL5 MTM1 MTMR2 RPS6KA6 SMARCA2 WNK3 HDAC1 RPL17 | 2.30e-07 | 730 | 157 | 16 | 34857952 | |
| Pubmed | Tcf1 and Lef1 are required for the immunosuppressive function of regulatory T cells. | 3.60e-07 | 4 | 157 | 3 | 30837262 | |
| Pubmed | TCF transcription factors: molecular switches in carcinogenesis. | 3.60e-07 | 4 | 157 | 3 | 10528152 | |
| Pubmed | Mapping canonical Wnt signaling in the developing and adult retina. | 3.60e-07 | 4 | 157 | 3 | 17065530 | |
| Pubmed | TCF-1 negatively regulates the suppressive ability of canonical and noncanonical Tregs. | 3.60e-07 | 4 | 157 | 3 | 36806938 | |
| Pubmed | DSC3 MARK3 PLEKHA6 LRCH3 MET PTPN13 EGFR WDR6 ELMO2 ITSN2 MTMR2 SNX1 | 5.32e-07 | 421 | 157 | 12 | 36976175 | |
| Pubmed | Hindgut defects and transformation of the gastro-intestinal tract in Tcf4(-/-)/Tcf1(-/-) embryos. | 6.97e-07 | 16 | 157 | 4 | 15057272 | |
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 21262773 | ||
| Pubmed | 8.97e-07 | 5 | 157 | 3 | 11447280 | ||
| Pubmed | Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2. | 8.97e-07 | 5 | 157 | 3 | 21285352 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | TEAD2 WWP1 FRK EGFR IKBKE KLHL23 RPS6KA6 TSSK1B HSP90AA1 FBXW11 HSP90AB1 | 1.12e-06 | 372 | 157 | 11 | 22939624 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | PRSS1 XRN2 LARP1 CEP192 LRCH3 NEK2 PNPLA6 UBR5 WDR6 MRPL49 HSP90AA1 HDAC1 RPL17 HSP90AB1 | 1.36e-06 | 639 | 157 | 14 | 23443559 |
| Pubmed | UBR2 DSC3 NCBP1 CEP192 PPM1H RINT1 PTPN13 PTPRE EGFR UCHL5 MTM1 MTMR2 KCNMA1 EIF2AK4 PLOD1 HSP90AA1 FBXW11 HSP90AB1 | 1.37e-06 | 1049 | 157 | 18 | 27880917 | |
| Pubmed | Thymine DNA glycosylase promotes transactivation of β-catenin/TCFs by cooperating with CBP. | 1.79e-06 | 6 | 157 | 3 | 24748645 | |
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 23152144 | ||
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 9488439 | ||
| Pubmed | SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts. | 1.79e-06 | 6 | 157 | 3 | 20128911 | |
| Pubmed | Vav family proteins couple to diverse cell surface receptors. | 1.79e-06 | 6 | 157 | 3 | 10938113 | |
| Pubmed | 1.79e-06 | 6 | 157 | 3 | 21566081 | ||
| Pubmed | Dazap2 modulates transcription driven by the Wnt effector TCF-4. | 1.79e-06 | 6 | 157 | 3 | 19304756 | |
| Pubmed | Function of Wnt/β-catenin in counteracting Tcf3 repression through the Tcf3-β-catenin interaction. | 1.83e-06 | 20 | 157 | 4 | 22573616 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PSMA3 ANXA6 LARP1 NCBP1 ZZEF1 WNK1 PARP6 FARSA UCHL5 MTMR2 PCYT2 PLEC PLOD1 SNX1 PUS7 TBCD HSP90AA1 WDR44 HDAC1 RPL17 HSP90AB1 | 2.68e-06 | 1455 | 157 | 21 | 22863883 |
| Pubmed | β-catenin and γ-catenin are dispensable for T lymphocytes and AML leukemic stem cells. | 3.12e-06 | 7 | 157 | 3 | 32820720 | |
| Pubmed | RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. | 3.12e-06 | 7 | 157 | 3 | 18772112 | |
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 19303461 | ||
| Pubmed | 3.12e-06 | 7 | 157 | 3 | 16204248 | ||
| Pubmed | Interaction of Hsp90 with the nascent form of the mutant epidermal growth factor receptor EGFRvIII. | 3.12e-06 | 7 | 157 | 3 | 12471035 | |
| Pubmed | 4.97e-06 | 8 | 157 | 3 | 26969725 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | WWP1 NCBP1 CEP192 PLEKHA6 COMMD3 PTPN13 PNPLA6 EGFR UBR5 WDR6 ITSN2 ZDHHC13 ABHD16A TBCD | 5.29e-06 | 719 | 157 | 14 | 35337019 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | PRSS1 XRN2 TCF7 TCF7L2 LARP1 PRSS3P2 ITSN2 PLEC LEF1 HSP90AA1 HDAC1 RPL17 HSP90AB1 | 5.86e-06 | 626 | 157 | 13 | 33644029 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | COL6A3 LETMD1 PRAMEF5 WNK1 FRK SYDE2 RPS6KA6 PLEC PRAMEF6 LARGE1 | 6.53e-06 | 363 | 157 | 10 | 14691545 |
| Pubmed | 7.43e-06 | 9 | 157 | 3 | 24034250 | ||
| Pubmed | 7.43e-06 | 9 | 157 | 3 | 26517842 | ||
| Pubmed | Wnt3a regulates Lef-1 expression during airway submucosal gland morphogenesis. | 7.43e-06 | 9 | 157 | 3 | 17335794 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | GABRB2 PSMA3 LARP1 CHSY1 NCBP1 WNK1 EGFR DNAJC11 DGCR8 PLOD1 WNK3 | 8.88e-06 | 462 | 157 | 11 | 31138677 |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 9.87e-06 | 163 | 157 | 7 | 22113938 | |
| Pubmed | BAG-2 acts as an inhibitor of the chaperone-associated ubiquitin ligase CHIP. | 1.06e-05 | 10 | 157 | 3 | 16207813 | |
| Pubmed | 1.14e-05 | 31 | 157 | 4 | 23469192 | ||
| Pubmed | Tcf7L2 is essential for neurogenesis in the developing mouse neocortex. | 1.45e-05 | 11 | 157 | 3 | 29751817 | |
| Pubmed | Expression of Tcf/Lef and sFrp and localization of beta-catenin in the developing mouse lung. | 1.45e-05 | 11 | 157 | 3 | 11731265 | |
| Pubmed | UBR2 TCF7 TCF7L2 MARK3 WWP1 LARP1 NCBP1 PLEKHA6 FARSA WDR87 DNAJC11 SMARCA2 LEF1 HSP90AA1 HDAC1 FBXW11 RPL17 HSP90AB1 | 1.47e-05 | 1247 | 157 | 18 | 27684187 | |
| Pubmed | 1.48e-05 | 33 | 157 | 4 | 18356246 | ||
| Pubmed | XRN2 ANXA6 MRPL10 TIAM2 LRCH3 FARSA WDR6 ELMO2 SYDE2 DNAJC11 ITSN2 VAV3 PLEC PLOD1 VAV2 | 1.88e-05 | 916 | 157 | 15 | 32203420 | |
| Pubmed | Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. | 1.93e-05 | 12 | 157 | 3 | 10631168 | |
| Pubmed | 1.93e-05 | 12 | 157 | 3 | 20805501 | ||
| Pubmed | 1.93e-05 | 12 | 157 | 3 | 15728722 | ||
| Pubmed | 1.93e-05 | 12 | 157 | 3 | 20642453 | ||
| Pubmed | 1.93e-05 | 12 | 157 | 3 | 32414917 | ||
| Pubmed | The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function. | 2.02e-05 | 2 | 157 | 2 | 35534539 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 24354805 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 23449277 | ||
| Pubmed | Highlights in NSCLC from the 2014 American Society of Clinical Oncology annual meeting. | 2.02e-05 | 2 | 157 | 2 | 25768032 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 27055285 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 28141869 | ||
| Pubmed | Differential expression of the HMG box factors TCF-1 and LEF-1 during murine embryogenesis. | 2.02e-05 | 2 | 157 | 2 | 8223271 | |
| Pubmed | Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function. | 2.02e-05 | 2 | 157 | 2 | 31960422 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 28939861 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 26829602 | ||
| Pubmed | VAV2 regulates epidermal growth factor receptor endocytosis and degradation. | 2.02e-05 | 2 | 157 | 2 | 20140013 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 16204645 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 11702203 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 26301867 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 27396618 | ||
| Pubmed | Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. | 2.02e-05 | 2 | 157 | 2 | 16273099 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 28913878 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 23677180 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 20489150 | ||
| Pubmed | A mouse tumor-specific transplantation antigen is a heat shock-related protein. | 2.02e-05 | 2 | 157 | 2 | 3458168 | |
| Pubmed | T-BET and EOMES Accelerate and Enhance Functional Differentiation of Human Natural Killer Cells. | 2.02e-05 | 2 | 157 | 2 | 34630413 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 20935204 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 21622718 | ||
| Pubmed | Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. | 2.02e-05 | 2 | 157 | 2 | 23197535 | |
| Pubmed | VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans. | 2.02e-05 | 2 | 157 | 2 | 20140222 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 23028720 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 30709927 | ||
| Pubmed | Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching. | 2.02e-05 | 2 | 157 | 2 | 21599871 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 10618391 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 26000960 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 19381876 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 24386407 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 18180459 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 25112829 | ||
| Pubmed | Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. | 2.02e-05 | 2 | 157 | 2 | 17694054 | |
| Pubmed | The Role of EGFR-Met Interactions in the Pathogenesis of Glioblastoma and Resistance to Treatment. | 2.02e-05 | 2 | 157 | 2 | 28004613 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 37406487 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 27450722 | ||
| Pubmed | Vav3-induced cytoskeletal dynamics contribute to heterotypic properties of endothelial barriers. | 2.02e-05 | 2 | 157 | 2 | 29858212 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 12657642 | ||
| Pubmed | Loss of Vav2 proto-oncogene causes tachycardia and cardiovascular disease in mice. | 2.02e-05 | 2 | 157 | 2 | 17202406 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 25653196 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 27421137 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 36756120 | ||
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 19047110 | ||
| Pubmed | Vagal afferents contribute to sympathoexcitation-driven metabolic dysfunctions. | 2.02e-05 | 2 | 157 | 2 | 30703063 | |
| Pubmed | EGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma. | 2.02e-05 | 2 | 157 | 2 | 24362532 | |
| Pubmed | 2.02e-05 | 2 | 157 | 2 | 28765916 | ||
| Pubmed | Heat shock protein HSP86 expression during mouse embryo development, especially in the germ-line. | 2.02e-05 | 2 | 157 | 2 | 12136260 | |
| GeneFamily | T-boxes | 1.63e-04 | 18 | 109 | 3 | 766 | |
| GeneFamily | Heat shock 90kDa proteins | 3.56e-04 | 5 | 109 | 2 | 586 | |
| GeneFamily | PRAME family | 3.93e-04 | 24 | 109 | 3 | 686 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 6.76e-04 | 66 | 109 | 4 | 722 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 7.42e-04 | 7 | 109 | 2 | 785 | |
| GeneFamily | Fibrinogen C domain containing|Angiopoietin like | 9.85e-04 | 8 | 109 | 2 | 905 | |
| GeneFamily | Patatin like phospholipase domain containing | 1.57e-03 | 10 | 109 | 2 | 466 | |
| GeneFamily | INO80 complex |SRCAP complex | 3.59e-03 | 15 | 109 | 2 | 595 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 3.59e-03 | 15 | 109 | 2 | 903 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP | PRSS1 TCF7 ZNF268 WWP1 NAP1L2 ANGPTL1 WDR6 MTMR2 RPS6KA6 LEF1 WNK3 WDR44 FBXW11 HSP90AB1 LARGE1 | 2.47e-06 | 587 | 156 | 15 | M40869 |
| Coexpression | GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN | 3.19e-06 | 199 | 156 | 9 | M6157 | |
| Coexpression | GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_UP | 1.19e-05 | 178 | 156 | 8 | M383 | |
| CoexpressionAtlas | alpha beta T cells, T.8Mem.Sp.OT1.d45.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | TCF7 WWP1 ANXA6 TBX21 CHSY1 EOMES PTPN13 NFATC2 IKBKE PLEC ARHGAP45 LEF1 | 1.14e-05 | 383 | 143 | 12 | GSM538403_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d8.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | XRN2 TCF7 WWP1 ANXA6 TBX21 CHSY1 EOMES PTPN13 NFATC2 IKBKE ARHGAP45 LEF1 | 1.26e-05 | 387 | 143 | 12 | GSM538392_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp.TCRbko, TCRd+ Vg2- CD44-, Spleen, avg-3 | TCF7 ANXA6 TBX21 CHSY1 DGKZ PPM1H EOMES TCP11L2 NFATC2 IKBKE PLEC LEF1 | 1.98e-05 | 405 | 143 | 12 | GSM605796_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d15.VSVOva, CD8+ CD45.1+, Spleen, avg-2 | TCF7 WWP1 ANXA6 TBX21 CHSY1 EOMES PTPN13 NFATC2 IKBKE ARHGAP45 LEF1 | 3.44e-05 | 361 | 143 | 11 | GSM538385_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3 | TCF7 ANXA6 TBX21 CHSY1 DGKZ SNRK EOMES IKBKE PLEC ARHGAP45 LEF1 | 5.74e-05 | 382 | 143 | 11 | GSM476684_500 |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-07 | 180 | 155 | 8 | 407fd8f61a757626e082b6e2eefd3a33276e6b71 | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-06 | 178 | 155 | 7 | 44634ba10da34307d6217646b221ddf5d7a65fb0 | |
| ToppCell | Control-B_naive-9|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.01e-06 | 120 | 155 | 6 | 62d3a731d36802c9da8674a042a8604cdb86263a | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-06 | 186 | 155 | 7 | 4dce1484653bb266e2305cbb306fb11eaf7892e2 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-06 | 186 | 155 | 7 | e23e1246914e230369a716d0d666b98383bf8512 | |
| ToppCell | Control-B_naive-9|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.62e-06 | 123 | 155 | 6 | 36d509eae874733f1a4f8189ad3000136ff6425e | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Liver / Manually curated celltypes from each tissue | 5.58e-06 | 195 | 155 | 7 | 972b09697b7b66fb8a27dfc0c0b05a844121f055 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo|Liver / Manually curated celltypes from each tissue | 5.58e-06 | 195 | 155 | 7 | c29c4ae95a756e3ced0f0747bbfe343590e5b8ab | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.77e-06 | 196 | 155 | 7 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.15e-05 | 161 | 155 | 6 | d72c572613f8eff3251cb7b1e9dcc76d193b2f21 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 164 | 155 | 6 | 950f87d9dacee45c9004a9bf894543de38f72ee5 | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 164 | 155 | 6 | c33910a6d87580902e9e7bd27afe6ea63b5eff8d | |
| ToppCell | droplet-Liver-nan-3m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 164 | 155 | 6 | bf0d3ad9016a0b8011a2385bb92f0a4f5edad1d6 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 166 | 155 | 6 | 8d535fab019356894b4dad3fbdbc4d2ad3e16082 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 166 | 155 | 6 | f56b1c0d6cb5353a16a2598bda905287f16d2c39 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 166 | 155 | 6 | a5074c96c6561273029aceb93402a7e038140f50 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-05 | 168 | 155 | 6 | 696b31bedbc7d40817a733e8c6ec2633404be619 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-05 | 169 | 155 | 6 | 2ad6ab74788c8738c9087811688a6128e5fa882a | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-05 | 169 | 155 | 6 | 3e608377b57e7f309d243467668c50abb499fcfe | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.33e-05 | 174 | 155 | 6 | b7f5492ce8098f7eb0aef30ee558d00738d59d0e | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.33e-05 | 174 | 155 | 6 | 71730503be3d9c839c4c9e950145e2101d682a1c | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.33e-05 | 174 | 155 | 6 | ee8ac51fa0b426ad7b7453371bb79c8bf8c1d358 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-AT1/AT2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.33e-05 | 174 | 155 | 6 | cafe4d6b5f08d8888e9db6e196c66df991c03e7b | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.44e-05 | 175 | 155 | 6 | f1d91cd49308cb501864cd16befaa43d6da828ca | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-05 | 175 | 155 | 6 | 392123b037ff48c924ebd020ac86891116a2dcd3 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-05 | 176 | 155 | 6 | a23d484aff5ad094333b2feae9106ca219514711 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-05 | 176 | 155 | 6 | 4e79c215cb6ace7d79b362a2e29a5228c54ce375 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 177 | 155 | 6 | 6d86b2f97426b552dff5ce6ddf0ead1285ed618e | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-mature_NK_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 177 | 155 | 6 | dba8b30a311051c22ca5f77697f5dbf9423c3ba0 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-mature_NK_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 177 | 155 | 6 | 93379bfd7484812bb45aa27c0324a75be9641685 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 177 | 155 | 6 | d8b1bbc224d062a57a6ad40b4b2af5d6e0fe63b3 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 177 | 155 | 6 | ac0cf03e2a1baf84db3ae245d59bbc6ae52c13be | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l9|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.66e-05 | 177 | 155 | 6 | d6b7d387e7485ff52ce27f51df8b8050f49fd941 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.78e-05 | 178 | 155 | 6 | 934a2a7b35a23b56e34d4d0ef68c271513ef1fe9 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 180 | 155 | 6 | 978728c89497d26287f73974fb738ad9fde61415 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 4.15e-05 | 181 | 155 | 6 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD8_Naive|Leuk-UTI / Disease, Lineage and Cell Type | 4.28e-05 | 182 | 155 | 6 | 3500a826d86beb98980e2b24e074b02e8e2f957e | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.41e-05 | 183 | 155 | 6 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 183 | 155 | 6 | 86c67f258fa25a818797df5d4df7f27b44cb5381 | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 184 | 155 | 6 | f9365feed31e48f3382588bab077f99c5a3f5b04 | |
| ToppCell | critical-Epithelial-Ionocyte|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.55e-05 | 184 | 155 | 6 | 58d36577eff814d46d72f031f3533d71549e3d6e | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 184 | 155 | 6 | b12fb85a064f715a4f0ada1df8e422c359b573cf | |
| ToppCell | facs-Marrow-T-cells-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.69e-05 | 185 | 155 | 6 | e1fd0a807def8c2127194108b1a30c6de7024292 | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.69e-05 | 185 | 155 | 6 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | NK-T_cells|World / lung cells shred on cell class, cell subclass, sample id | 4.83e-05 | 186 | 155 | 6 | 279ab91ebca37a39b8907409e07f8b533df67542 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 187 | 155 | 6 | 1387981d224cb9e846ed18e366736855a4eb827e | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.12e-05 | 188 | 155 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.28e-05 | 189 | 155 | 6 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.43e-05 | 190 | 155 | 6 | 600b9674197f743dea1d19d3df0fc993b6e6aa25 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 191 | 155 | 6 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.76e-05 | 192 | 155 | 6 | c5f77c2103841505d13e09173549811312ef2f01 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.76e-05 | 192 | 155 | 6 | e981162f387a31111c0ae8355dbe9db5785c4838 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.93e-05 | 193 | 155 | 6 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-T_and_NK|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.93e-05 | 193 | 155 | 6 | 1d4be03829f4bba34a0b28984e1ea51965dc75fb | |
| ToppCell | COVID-19_Mild-Non-classical_Monocyte|COVID-19_Mild / Disease condition and Cell class | 6.27e-05 | 195 | 155 | 6 | dd00facd20a661ef23fa7fd9a02ee377b8f2d1b9 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-T_and_NK|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.27e-05 | 195 | 155 | 6 | 0d3600586b5698dc727687139e8cdf624af541eb | |
| ToppCell | COVID-19_Mild-Non-classical_Monocyte-|COVID-19_Mild / Disease condition and Cell class | 6.27e-05 | 195 | 155 | 6 | 0295d9897830987eec74f51178e14fb0a83723dc | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.64e-05 | 197 | 155 | 6 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.64e-05 | 197 | 155 | 6 | 0e93800d5df652a9c691c66a3f75a2e8979aed8e | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD8-Tem/emra_CD8|blood / Manually curated celltypes from each tissue | 6.64e-05 | 197 | 155 | 6 | 13e6611cde9364f0c1bf681b0b26c4d2725e5f4a | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.64e-05 | 197 | 155 | 6 | 9acf6719126ca335f584811a72b46af485d67437 | |
| ToppCell | Control-Lymphoid-CD4_T_cells|Control / Condition, Lineage and Cell class | 6.64e-05 | 197 | 155 | 6 | dad6479caac07c1536f2b3082a51d61ae08beca0 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.64e-05 | 197 | 155 | 6 | 82eab092d075507889fe1d8845c754a7f0bed30a | |
| ToppCell | (2)_Fibroblasts-(24)_Fibro-5|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.64e-05 | 197 | 155 | 6 | 83a4b79fbfa1cf63441dee4424c3b87c988287bf | |
| ToppCell | severe_COVID-19-NK|severe_COVID-19 / disease group, cell group and cell class (v2) | 6.83e-05 | 198 | 155 | 6 | 7f51e37516f717e424190e6584f1c74d357e2da4 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 6.83e-05 | 198 | 155 | 6 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.02e-05 | 199 | 155 | 6 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | distal-1-Hematologic-CD8+_Naive_T|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.02e-05 | 199 | 155 | 6 | 56eca2f1e6ac1bba0a742a1824c54d0d97541ff1 | |
| ToppCell | Mild-Lymphoid-NK|Mild / Condition, Lineage, Cell class and cell subclass | 7.02e-05 | 199 | 155 | 6 | ae8b16e5463c3c41807fef187ee9f501df07e452 | |
| ToppCell | distal-Hematologic-CD8+_Naive_T|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.22e-05 | 200 | 155 | 6 | 127389d7a96aaec29b280e77d0a7a30856e47360 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.22e-05 | 200 | 155 | 6 | 1dd0141e87902d96a76edcd966988f61a532c808 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.22e-05 | 200 | 155 | 6 | 7f79ab7737188b1f7fb5c2a0b1d6d2a565d36385 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.22e-05 | 200 | 155 | 6 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | Sepsis-Leuk-UTI|Sepsis / Disease, condition lineage and cell class | 7.22e-05 | 200 | 155 | 6 | 7d92b24c0c888dd46e40b7e3c6c2645c3604f132 | |
| ToppCell | Control-Lymphoid_T/NK|Control / Disease group, lineage and cell class | 7.22e-05 | 200 | 155 | 6 | b5d5eead192a22c6b5ea699fe36873809fe6e3e2 | |
| ToppCell | Biopsy_Control_(H.)-Immune-T_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.22e-05 | 200 | 155 | 6 | 3545706d133b29df61affe8ac47b6c9fe85f7775 | |
| ToppCell | distal-1-Hematologic-Natural_Killer|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.22e-05 | 200 | 155 | 6 | 69756eba4b9b6cd5115aa7b76dfc36bb70097993 | |
| ToppCell | ASK452-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.89e-05 | 132 | 155 | 5 | 49ba24e24b3127b5257a88a0ee0246c9843c580a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-04 | 133 | 155 | 5 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 144 | 155 | 5 | bf26a7f9eefa229ef489b66fd74cebbd4720da6c | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 150 | 155 | 5 | a3a4710820a244116a26204f40e7113a1e7236c5 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 150 | 155 | 5 | 13dcd519dacf08d5852aa3e029e0a3308de07321 | |
| ToppCell | Lymphoid|World / shred on cell class and cell subclass (v4) | 1.86e-04 | 151 | 155 | 5 | d7577b2416b91a8be0198dea703385f86f816059 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Six3|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.92e-04 | 82 | 155 | 4 | 47b131333ab84b70d2abe3fc17e63de504214b1b | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D2|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 153 | 155 | 5 | 5fb7d92cddc816c64071465e955ed0ea3bb45316 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.03e-04 | 154 | 155 | 5 | 44d4d99b08216c0901e3bc32743fa0a8b85b5149 | |
| ToppCell | Control-Epithelial-Ionocyte|Epithelial / Disease state, Lineage and Cell class | 2.10e-04 | 155 | 155 | 5 | 4b9369b203a4d7071c56d3d8e6b450e9a0121c41 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-04 | 157 | 155 | 5 | b337937a88f62030114a28d70a63168417672767 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-04 | 158 | 155 | 5 | 9f0987eaf1766aadb5714b68df7a5d310ea5a57a | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 159 | 155 | 5 | 94bc6ab248a8f02ccbc0facd24e0c7e9fda687d2 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.36e-04 | 159 | 155 | 5 | 2233fee5dcdb6c7dee5b1bd8efbc07d86b339927 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 162 | 155 | 5 | 15d5d31a75e26bcd41919a00300c68e9f00f0002 | |
| ToppCell | droplet-Fat-Scat-18m-Lymphocytic-T_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 163 | 155 | 5 | b1a38985d0560dbc6ca66f711d52a208303860ca | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 164 | 155 | 5 | 9fed5df40f50bde35db8bf89c291cbdc0e104112 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 164 | 155 | 5 | e712d6b89461f741dbd773ba9a27ecaddf97cbaa | |
| ToppCell | Healthy-NK_CD56bright|Healthy / disease group, cell group and cell class | 2.72e-04 | 164 | 155 | 5 | ed193211965accba60a256d3e6c159f0fc911d8b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-04 | 164 | 155 | 5 | 6fb2136168f430babfeb81ca7e151ca7a8092ec4 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 165 | 155 | 5 | eeb58d4db64ad37dc6b441eab22b05c24862e1a9 | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 165 | 155 | 5 | 54706631d819f401988e2c733dd6e59401a3585d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 165 | 155 | 5 | 475905d608fac628960188ae4a18010b8097417e | |
| Disease | total blood protein measurement | TCF7 TCF7L2 ZNF618 EOMES C4orf17 FRK IKBKE MTM1 ARHGAP45 HYDIN | 6.70e-05 | 449 | 142 | 10 | EFO_0004536 |
| Disease | neurodegenerative disease (implicated_via_orthology) | 7.50e-05 | 145 | 142 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | cognitive decline measurement, disease progression measurement | 1.37e-04 | 4 | 142 | 2 | EFO_0007710, EFO_0008336 | |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 3.41e-04 | 6 | 142 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | visceral:subcutaneous adipose tissue ratio | 3.68e-04 | 70 | 142 | 4 | EFO_0004767 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 6.32e-04 | 8 | 142 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | blindness (implicated_via_orthology) | 6.32e-04 | 8 | 142 | 2 | DOID:1432 (implicated_via_orthology) | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 8.10e-04 | 9 | 142 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | pancreatitis (biomarker_via_orthology) | 8.78e-04 | 39 | 142 | 3 | DOID:4989 (biomarker_via_orthology) | |
| Disease | biological sex | 8.91e-04 | 230 | 142 | 6 | PATO_0000047 | |
| Disease | Pulmonary Hypertension | 9.46e-04 | 40 | 142 | 3 | C0020542 | |
| Disease | asthma | COL6A3 TCF7 TBX21 TIAM2 NFATC2 ITSN2 USP32 SMARCA2 MROH7 C1D TBXT | 1.06e-03 | 751 | 142 | 11 | MONDO_0004979 |
| Disease | fibromuscular dysplasia | 1.25e-03 | 44 | 142 | 3 | EFO_1000938 | |
| Disease | multiple sclerosis symptom measurement | 1.42e-03 | 46 | 142 | 3 | EFO_0803536 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.71e-03 | 49 | 142 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Cardiomyopathy, Familial Idiopathic | 1.81e-03 | 50 | 142 | 3 | C1449563 | |
| Disease | sitting height ratio | 1.92e-03 | 51 | 142 | 3 | EFO_0007118 | |
| Disease | asymmetric dimethylarginine measurement | 2.01e-03 | 14 | 142 | 2 | EFO_0010463 | |
| Disease | pancreatitis | 2.64e-03 | 16 | 142 | 2 | EFO_0000278 | |
| Disease | phosphatidylcholine 38:6 measurement | 2.64e-03 | 16 | 142 | 2 | EFO_0010388 | |
| Disease | Idiopathic pulmonary arterial hypertension | 2.64e-03 | 16 | 142 | 2 | C3203102 | |
| Disease | uric acid measurement | 2.86e-03 | 610 | 142 | 9 | EFO_0004761 | |
| Disease | colon cancer (is_marker_for) | 2.91e-03 | 59 | 142 | 3 | DOID:219 (is_marker_for) | |
| Disease | Benign neoplasm of stomach | 2.98e-03 | 17 | 142 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 2.98e-03 | 17 | 142 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 2.98e-03 | 17 | 142 | 2 | C0154060 | |
| Disease | phosphatidylcholine 40:6 measurement | 2.98e-03 | 17 | 142 | 2 | EFO_0010389 | |
| Disease | Familial primary pulmonary hypertension | 2.98e-03 | 17 | 142 | 2 | C0340543 | |
| Disease | acute pancreatitis | 3.35e-03 | 18 | 142 | 2 | EFO_1000652 | |
| Disease | maximum cigarettes per day measurement | 3.35e-03 | 18 | 142 | 2 | EFO_0009264 | |
| Disease | eosinophil percentage of leukocytes | 3.36e-03 | 746 | 142 | 10 | EFO_0007991 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 3.51e-03 | 63 | 142 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | body mass index, high density lipoprotein cholesterol measurement | 3.73e-03 | 19 | 142 | 2 | EFO_0004340, EFO_0004612 | |
| Disease | type 1 diabetes mellitus (biomarker_via_orthology) | 3.73e-03 | 19 | 142 | 2 | DOID:9744 (biomarker_via_orthology) | |
| Disease | triglyceride measurement, body mass index | 3.73e-03 | 19 | 142 | 2 | EFO_0004340, EFO_0004530 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 3.73e-03 | 19 | 142 | 2 | DOID:4928 (is_marker_for) | |
| Disease | MYELODYSPLASTIC SYNDROME | 4.17e-03 | 67 | 142 | 3 | C3463824 | |
| Disease | Stomach Carcinoma | 4.55e-03 | 21 | 142 | 2 | C0699791 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QMIVLQSLHKYQPRL | 386 | O95936 | |
| YLRLNHEGKIVLRMR | 56 | Q7Z4R8 | |
| VKLSHPNVVRYLAMN | 351 | Q9P2K8 | |
| ARSYNKQMRPAILDH | 136 | Q9H981 | |
| LKLLQHRYPRVMAEE | 451 | O95870 | |
| TQLYMQLLHEIIRKR | 131 | O95841 | |
| QLYMQLLHEIIRKRD | 136 | Q9UKU9 | |
| LHEYMQRVLKVRPVY | 516 | Q8WYQ5 | |
| YPHLRRVFQEFIKMT | 556 | P08133 | |
| YVMDPDHRLLLRNTK | 296 | Q13367 | |
| IYDRLNRTPLMKAVH | 96 | Q9H560 | |
| YMQLSHIQEPRARQV | 751 | Q68CQ1 | |
| AEMYQPLLEKRRQII | 141 | Q9ULW6 | |
| QTPRKMRHVYNSELL | 256 | Q86YS3 | |
| DTMQPIERKRQGYIH | 1201 | Q9NZM3 | |
| EAHVRAQLIKPYMTQ | 216 | P48050 | |
| LARKERQLHMQLYPG | 351 | Q9UJU2 | |
| NMLFVEIPEYRNKHI | 636 | Q13469 | |
| ISIIRLNRQLHTPMY | 46 | Q8NGM9 | |
| HLPSEVLYMLKNVRV | 181 | Q8IY17 | |
| FAMHRLIIKPYLRAQ | 401 | Q9NVH1 | |
| NKILIVTQTPHYMRR | 641 | Q6PKG0 | |
| EDPQTHSNRIYRMIK | 671 | P08238 | |
| RLQRPHMVQTLEQYE | 666 | P23469 | |
| YPVNLLRNVAMKHIS | 541 | O95461 | |
| KTEDMRRYLHQNRVP | 431 | Q96II8 | |
| EALRVMHQIISKYPL | 156 | Q92619 | |
| NPDMLVVHEKRELYR | 511 | Q9P2G4 | |
| HPRKLLMQDLVQENY | 241 | P43356 | |
| IMRVISIKNYHPKIR | 506 | Q12791 | |
| SYLKRRQKTHVPMLQ | 201 | Q09161 | |
| EIITRMLNLKDYHRP | 246 | P51955 | |
| KFHQLPYREMEHLRQ | 116 | Q6P1Q0 | |
| KPHRIRMTHNLLLNY | 31 | Q13547 | |
| HINRDAPGREQKYML | 206 | Q9Y3R5 | |
| HPDMYERAVLRKPQQ | 181 | Q14164 | |
| HPVKQELERIRVYMN | 81 | Q13901 | |
| MPKISLQHYANLFIR | 121 | Q53TS8 | |
| NNFMLYKEDRIHIPI | 56 | P43629 | |
| KNYPIMNLHERTLSV | 261 | Q99447 | |
| KPLHYLNIMNRLVCI | 126 | Q8NH70 | |
| HINSYLKPMLQRDFI | 106 | Q9UKB1 | |
| RMKPQEPIHNRYKEL | 586 | Q13614 | |
| LGQYMQPTRRHLKVE | 306 | O43766 | |
| KNRMIRLHPDGTVLY | 136 | P47870 | |
| PRYGNHVVLLLKMQV | 501 | P03971 | |
| LMRYGQHPNIITLKD | 471 | Q9UK32 | |
| HRKMGNPQRALLYLV | 256 | O15287 | |
| VMYINAQLPREQRHR | 251 | Q6P9B6 | |
| LHEQKQMIGERLYPL | 541 | Q4VXU2 | |
| HLPSEVLYMLKNVRV | 131 | Q6ZV29 | |
| QRLLRLHYPQKHMRL | 306 | Q02809 | |
| EILNHMKRATQIPSY | 266 | P15309 | |
| LQVAAMNYRLRPLEK | 431 | Q8IZJ4 | |
| EKLDRPLVRMYQRHV | 391 | Q8IYK2 | |
| IKTNQLHRMYRPAYL | 136 | Q9UBI1 | |
| YKLHQVNRPLTMRKD | 286 | P15976 | |
| MKNLRHPKLIQLYAV | 281 | P42685 | |
| QRYLVIQGDERMHLP | 976 | P00533 | |
| YRPRTMNLENRKHQG | 4691 | Q4G0P3 | |
| RERNQIFHEVPLKFM | 336 | Q659A1 | |
| KIRSLIYNALNPMHK | 251 | Q8NBE8 | |
| IYNALNPMHKEISQR | 256 | Q8NBE8 | |
| MHTRLKYSILQQTPR | 276 | Q14574 | |
| RPIKTEMAHQLYVLQ | 276 | Q96JJ3 | |
| LLIRRNNMKIPVAEY | 301 | Q53FE4 | |
| LEKFRNMRSQHPYVL | 1911 | P12111 | |
| KHILNIMVRDQEFPY | 1531 | Q8TDW7 | |
| ITLSNHRKQRMEPLY | 2451 | Q8TDW7 | |
| HRKQRMEPLYSLNVS | 2456 | Q8TDW7 | |
| KETYLHIMLNRRPAA | 176 | P60827 | |
| HIMLNRRPAAVLYAQ | 181 | P60827 | |
| VLLMRYAPRIAHNII | 266 | Q5I0G3 | |
| FREVRIMKILNHPNI | 101 | P27448 | |
| QYMLQKERVEPHQLA | 141 | Q5SQI0 | |
| YRRALLHKPEMIKQI | 1996 | Q8TEP8 | |
| IRKDDIIALYPQLMH | 381 | P22680 | |
| MDLNNLVRHLLYPVT | 156 | Q9NYL5 | |
| HRQALRYIQTMKPTV | 856 | Q8WYP5 | |
| PQTHANRIYRMIKLG | 681 | P07900 | |
| ALEMYRKVHNLRILA | 336 | Q13574 | |
| HIPYNTLAKMRELER | 256 | Q9NZU1 | |
| IISRHYNKDERMIPL | 376 | Q8IVF4 | |
| PQNVHRILINLMKYL | 976 | Q8IVF4 | |
| IRTKNLLPMYQEAEH | 546 | Q92622 | |
| IKMRPYDANKRHRVF | 141 | Q99500 | |
| TPYLGHMRNLQKLVL | 131 | H0Y7S4 | |
| LMLHYEFLQRVKRLP | 311 | P07358 | |
| LRPFIHQRSQMFKDL | 936 | B7ZC32 | |
| ASLYPHRKNVIVNME | 976 | Q12923 | |
| LHYPVIMNQRTRAKL | 131 | Q9H207 | |
| QHRMPSKDELVQRYN | 526 | Q2NL67 | |
| LLNPLIYTLRNHEMK | 281 | Q8NGI6 | |
| VPYNNLLIEMLHAKR | 526 | O00482 | |
| YFQRDSPHLLVRMKR | 196 | Q9UBD0 | |
| VLPYMKHGDLRNFIR | 1156 | P08581 | |
| YLRQKKERPHMLNLS | 1051 | Q5VT97 | |
| AQMIRNEYRKLHPVL | 176 | Q96BQ3 | |
| HPKYNRIILNNDIML | 96 | Q8NHM4 | |
| LMEHKRLNGPYLIIV | 766 | P51531 | |
| VGYKRMRLPNLLEHE | 66 | Q5T4F7 | |
| LQLPMDYVQRVKRTH | 286 | Q9Y285 | |
| MSLRPHLQRQLVEYE | 231 | Q8N4U5 | |
| NNFMLYKEDRIHVPI | 56 | Q14943 | |
| TNRMTPEKHLNYLRN | 351 | Q8IWB4 | |
| HLEMLQKAQVSYRTP | 866 | Q8TE76 | |
| IIPRNNRLMYIHSYQ | 466 | Q96PZ0 | |
| DIRKARQHMEVELPY | 401 | Q9BX95 | |
| MSPEKLQQYRQVHLL | 356 | Q9H173 | |
| FLHKLRQLPERYMMN | 386 | Q15562 | |
| HIQVNKAPKMRRRTY | 116 | P18621 | |
| YLQNQRIIHRDMKPD | 136 | Q8WU08 | |
| VRRSRMHNIPVYKDI | 86 | Q13405 | |
| CMKLVQHPNIVRLYE | 66 | Q9NRH2 | |
| KKMTVPVRRHAYLQQ | 461 | Q86X52 | |
| IRRKHNYLPFIMELL | 286 | Q9Y5K5 | |
| PYLGHMRNLQKLVLS | 226 | Q5VXH4 | |
| REAVRLNPKYVHAMN | 506 | Q5T4D3 | |
| EIARLRKMELEPQHY | 896 | Q9Y2H5 | |
| PREIQVMKVLRHKYL | 71 | Q6SA08 | |
| LALKHLPRMYNQVKV | 521 | Q5T7W0 | |
| LLVHQRMHTREKPYE | 851 | Q14587 | |
| QYTMVFHPAREKVLR | 606 | Q8IUH4 | |
| KMRQLEPSHYGLQLR | 841 | Q8IVF5 | |
| KEINRVLYPVASMRH | 516 | Q13496 | |
| HFQRQKLMAVTEYIP | 41 | Q7Z7H8 | |
| ALERYLQRIVNHPTM | 241 | Q13596 | |
| IQVMLTPLQKRFRYH | 306 | Q6NUQ1 | |
| ERQRLQYLAFMQPHL | 311 | Q9ULR3 | |
| HKIMDYIRRQRAQPN | 206 | Q9H0D6 | |
| ELARKERQLHMQLYP | 401 | Q9NQB0 | |
| PYLGHMRNLQKLVLS | 226 | Q5TYX0 | |
| INPLTLHIMRRTKEY | 381 | Q5JSH3 | |
| NIPLKHLADRVAMYV | 106 | P25788 | |
| GQIMLNSLHKYEPRI | 156 | O15178 | |
| RPSQRHQMLYLRQKD | 146 | Q9Y2I9 | |
| RHKPLLIDMNKVYRQ | 336 | Q15149 | |
| AQTYVPRLVRMKVFH | 106 | Q9BQ65 | |
| RMIKRVQNLLGHYLI | 51 | Q9NNW5 | |
| LARKERQLHMQLYPG | 321 | P36402 | |
| KVNIPFVRLNYQHRM | 1061 | Q9P2E3 | |
| YKNPRRNLRCHMVER | 56 | Q8TA94 | |
| KDLIYHMLQPDVNRR | 246 | Q9BXA7 | |
| PNRKMYHLCIVNLVI | 536 | Q86WT1 | |
| APLHILRAIYELQMK | 2476 | O43149 | |
| LEVVHMIYQLPTRVR | 1211 | A6NGW2 | |
| RVIMDKYQEQPHLLD | 61 | Q9BTW9 | |
| AQMIRNEYRKLHPVL | 176 | A6NCK2 | |
| MPRHEVYVLLIRNIF | 686 | Q6UXY8 | |
| HPQYDRKTLNNDIML | 96 | P07477 | |
| QDLLVVPMQRVLKYH | 326 | P52735 | |
| MLKGLQHPNIVRFYD | 271 | Q9H4A3 | |
| FQQIMALKPYDLRRR | 581 | Q9H0M0 | |
| LQNAPYLEVHKDMIR | 976 | Q8IWV8 | |
| VPVLQVIMHSRYRAQ | 181 | Q9UI38 | |
| ALYHVLRMLQQRYPK | 2731 | Q6ZQQ6 | |
| QMIVLQSLHKYQPRL | 256 | Q9UL17 | |
| RHLYELNRTNPIGMK | 766 | Q8NFA0 | |
| MYPEINRFLKLLHQC | 426 | Q6NUM6 | |
| RKYAEHRMLVVAEQP | 2636 | O95071 | |
| YQLPQNRRMTHLAQK | 366 | Q9H6D3 | |
| RDLLVVPMQRVLKYH | 321 | Q9UKW4 | |
| VPMQRVLKYHLLLQE | 326 | Q9UKW4 | |
| EMLKGLQHPNIVRFY | 196 | Q9BYP7 | |
| MLRAKNQLFLLSPHY | 1 | P22033 |